Atlas Trials

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata

Clinical trial NCT07617597 · RECRUITING

Trial details

NCT number
NCT07617597
Sponsor
Sun Pharma Japan Limited
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Alopecia Areata
Start date
2026-06-19
Primary completion
2028-02-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.